Literature DB >> 2029720

Respiratory tract infections: when is antibiotic therapy indicated?

H Lode1.   

Abstract

Antibiotic therapy of purulent bronchitis is a matter of continuing controversy. However, recent studies on the pathogenicity of airway hyperreactivity, granulocyte-mediated bronchial obstruction, and histamine production of Haemophilus influenzae indicate an important role for viral and bacterial infections in exacerbations of chronic obstructive lung disease (COLD). Considering the different stages of COLD in relation to lung function, bacterial pathogens, and relevant findings and symptoms of the individual patient, antibiotic treatment should be based on three different degrees of severity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2029720

Source DB:  PubMed          Journal:  Clin Ther        ISSN: 0149-2918            Impact factor:   3.393


  5 in total

1.  Acute exacerbation of chronic bronchitis: disease-specific issues that influence the cost-effectiveness of antimicrobial therapy.

Authors:  S Saint; K R Flaherty; P Abrahamse; F J Martinez; A M Fendrick
Journal:  Clin Ther       Date:  2001-03       Impact factor: 3.393

Review 2.  The chronic obstructive pulmonary disease exacerbation.

Authors:  P A Sherk; R F Grossman
Journal:  Clin Chest Med       Date:  2000-12       Impact factor: 2.878

Review 3.  Role of antimicrobial agents in the management of exacerbations of COPD.

Authors:  Sat Sharma; Nicholas Anthonisen
Journal:  Treat Respir Med       Date:  2005

Review 4.  Acute bronchitis: state of the art diagnosis and therapy.

Authors:  Fernando J Martinez
Journal:  Compr Ther       Date:  2004

Review 5.  Airway infection.

Authors:  M Niroumand; R F Grossman
Journal:  Infect Dis Clin North Am       Date:  1998-09       Impact factor: 5.982

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.